home ꄲ R&D ꄲ Fedratinib

Fedratinib

CAS: 936091-26-8

Indication: To treat myeloproliferative diseases including myelofibrosis.

Fedratinib

넳 넲

Address: RM503, Wanhai Building B, Nanhai Avenue, Nanshan District,Shenzhen 518067 P.R. China.

Tel: (86) 755-82960263 (For All)

Web: www.haorui.com

Email: info@haorui.com

끸

Submit